150 related articles for article (PubMed ID: 9497025)
1. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition.
Mansbach RS; Brooks EW; Sanner MA; Zorn SH
Psychopharmacology (Berl); 1998 Jan; 135(2):194-200. PubMed ID: 9497025
[TBL] [Abstract][Full Text] [Related]
2. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
[TBL] [Abstract][Full Text] [Related]
3. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
Merchant KM; Gill GS; Harris DW; Huff RM; Eaton MJ; Lookingland K; Lutzke BS; Mccall RB; Piercey MF; Schreur PJ; Sethy VH; Smith MW; Svensson KA; Tang AH; Vonvoigtlander PF; Tenbrink RE
J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
[TBL] [Abstract][Full Text] [Related]
5. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?
Varty GB; Higgins GA
Behav Pharmacol; 1998 Sep; 9(5-6):445-55. PubMed ID: 9832930
[TBL] [Abstract][Full Text] [Related]
6. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.
Weber M; Chang WL; Durbin JP; Park PE; Luedtke RR; Mach RH; Swerdlow NR
Pharmacol Biochem Behav; 2009 Aug; 93(2):141-7. PubMed ID: 19426754
[TBL] [Abstract][Full Text] [Related]
7. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
Caine SB; Geyer MA; Swerdlow NR
Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
[TBL] [Abstract][Full Text] [Related]
8. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A
Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
[TBL] [Abstract][Full Text] [Related]
9. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
10. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
[TBL] [Abstract][Full Text] [Related]
12. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
[TBL] [Abstract][Full Text] [Related]
13. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
Swerdlow NR; Keith VA; Braff DL; Geyer MA
J Pharmacol Exp Ther; 1991 Feb; 256(2):530-6. PubMed ID: 1825226
[TBL] [Abstract][Full Text] [Related]
14. FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia.
Boeckler F; Russig H; Zhang W; Löber S; Schetz J; Hübner H; Ferger B; Gmeiner P; Feldon J
Psychopharmacology (Berl); 2004 Aug; 175(1):7-17. PubMed ID: 15007532
[TBL] [Abstract][Full Text] [Related]
15. Dissociable effects of the
Lins BR; Marks WN; Phillips AG; Howland JG
Psychopharmacology (Berl); 2017 Apr; 234(7):1079-1091. PubMed ID: 28180960
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J
Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323
[TBL] [Abstract][Full Text] [Related]
17. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
18. A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile.
Okuyama S; Kawashima N; Chaki S; Yoshikawa R; Funakoshi T; Ogawa SI; Suzuki Y; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
Life Sci; 1999; 65(20):2109-25. PubMed ID: 10579464
[TBL] [Abstract][Full Text] [Related]
19. D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia.
Hoffman DC; Donovan H
Psychopharmacology (Berl); 1994 Aug; 115(4):447-53. PubMed ID: 7871088
[TBL] [Abstract][Full Text] [Related]
20. PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats.
Martin-Iverson MT; Else D
Psychopharmacology (Berl); 2000 Jul; 151(1):38-48. PubMed ID: 10958115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
